Remifentanil-based analgesia and sedation is well tolerated when administered for up to 10 days in mechanically ventilated ICU patients

A. Karabinis, Manu Malbrain, J. Bakker, T. Jensen, P. Germann, D. Breen, P. Parkinson

Research output: Unpublished contribution to conferencePoster

Original languageEnglish
Publication statusPublished - 2004
Event24th International Symposium on Intensive Care Medicine - Congress Center, Brussels, Belgium
Duration: 30 Mar 20042 Apr 2004

Conference

Conference24th International Symposium on Intensive Care Medicine
CountryBelgium
CityBrussels
Period30/03/042/04/04

Keywords

  • Remifentanil-based analgesia
  • sedation
  • ICU patients

Cite this